Literature DB >> 11297189

Disparities in hormone replacement therapy use by socioeconomic status in a primary care population.

C Finley1, E W Gregg, L J Solomon, E Gay.   

Abstract

The use of hormone replacement therapy (HRT) is a controversial decision for many women, yet few studies have evaluated the socio-demographic, psychological, and behavioral correlates of HRT use. This cross-sectional, mailed survey evaluated the associations of socioeconomic status, preventive health behaviors, knowledge and perceptions about HRT-related risks and benefits with HRT use among 428 women 50-70 years old in Vermont. The overall prevalence of HRT use was 40%. Women of moderate to high income were three times more likely than those of low income to use HRT. HRT use was significantly higher among women whose physician had encouraged use (58%) than among those who received ambivalent recommendations from their physicians (20%). Hysterectomy, higher income, younger age, regular adherence to cervical cancer screening, and recommendation by a provider were significantly associated with HRT use in multivariate analyses. There were no differences in HRT use according to level of concern about heart disease, osteoporosis, or breast cancer. A recommendation by a health care provider is a powerful predictor of HRT use, but disparities in use exist by socioeconomic status. Future research should examine why lower income women are less likely to use HRT and whether the discrepancy is due to inconsistent recommendations by health care providers.

Entities:  

Mesh:

Year:  2001        PMID: 11297189     DOI: 10.1023/a:1026537114638

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  18 in total

Review 1.  Hormone therapy to prevent disease and prolong life in postmenopausal women.

Authors:  D Grady; S M Rubin; D B Petitti; C S Fox; D Black; B Ettinger; V L Ernster; S R Cummings
Journal:  Ann Intern Med       Date:  1992-12-15       Impact factor: 25.391

2.  Postmenopausal estrogen and prevention bias.

Authors:  E Barrett-Connor
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

3.  Prior to use of estrogen replacement therapy, are users healthier than nonusers?

Authors:  K A Matthews; L H Kuller; R R Wing; E N Meilahn; P Plantinga
Journal:  Am J Epidemiol       Date:  1996-05-15       Impact factor: 4.897

Review 4.  The relationship between socioeconomic status and health: a review of the literature.

Authors:  J S Feinstein
Journal:  Milbank Q       Date:  1993       Impact factor: 4.911

5.  Use of hormone replacement therapy by postmenopausal women in the United States.

Authors:  N L Keating; P D Cleary; A S Rossi; A M Zaslavsky; J Z Ayanian
Journal:  Ann Intern Med       Date:  1999-04-06       Impact factor: 25.391

6.  Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study.

Authors:  K M Brett; J H Madans
Journal:  Am J Epidemiol       Date:  1997-03-15       Impact factor: 4.897

7.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

8.  The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.

Authors:  G A Colditz; S E Hankinson; D J Hunter; W C Willett; J E Manson; M J Stampfer; C Hennekens; B Rosner; F E Speizer
Journal:  N Engl J Med       Date:  1995-06-15       Impact factor: 91.245

9.  Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.

Authors:  M J Stampfer; G A Colditz; W C Willett; J E Manson; B Rosner; F E Speizer; C H Hennekens
Journal:  N Engl J Med       Date:  1991-09-12       Impact factor: 91.245

10.  Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group.

Authors:  J A Cauley; D G Seeley; K Ensrud; B Ettinger; D Black; S R Cummings
Journal:  Ann Intern Med       Date:  1995-01-01       Impact factor: 25.391

View more
  8 in total

1.  Data analysis of epidemiological studies: part 11 of a series on evaluation of scientific publications.

Authors:  Meike Ressing; Maria Blettner; Stefanie J Klug
Journal:  Dtsch Arztebl Int       Date:  2010-03-19       Impact factor: 5.594

2.  The role of socioeconomic status on hip fracture.

Authors:  D S Zingmond; N F Soohoo; S L Silverman
Journal:  Osteoporos Int       Date:  2006-06-15       Impact factor: 4.507

Review 3.  Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis.

Authors:  M Constanza Camargo; Yasuyuki Goto; Jovanny Zabaleta; Douglas R Morgan; Pelayo Correa; Charles S Rabkin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10-25       Impact factor: 4.254

4.  Osteoporosis medications used by older African-American women: effects of socioeconomic status and psychosocial factors.

Authors:  Christine G Unson; Richard Fortinsky; Karen Prestwood; Susan Reisine
Journal:  J Community Health       Date:  2005-08

5.  Developing profiles of postmenopausal women being prescribed estrogen therapy to prevent osteoporosis.

Authors:  Mayur M Amonkar; Reema Mody
Journal:  J Community Health       Date:  2002-10

6.  Limited educational attainment and radiographic and symptomatic knee osteoarthritis: a cross-sectional analysis using data from the Johnston County (North Carolina) Osteoarthritis Project.

Authors:  Leigh F Callahan; Jack Shreffler; Bernadette C Siaton; Charles G Helmick; Britta Schoster; Todd A Schwartz; Jiu-Chiuan Chen; Jordan B Renner; Joanne M Jordan
Journal:  Arthritis Res Ther       Date:  2010-03-18       Impact factor: 5.156

7.  Reproductive and hormonal risk factors for sarcoidosis: a nested case-control study.

Authors:  Marina Dehara; Michael C Sachs; Susanna Kullberg; Johan Grunewald; Anders Blomberg; Elizabeth V Arkema
Journal:  BMC Pulm Med       Date:  2022-01-24       Impact factor: 3.317

8.  Symptom reporting and quality of life in the Estonian Postmenopausal Hormone Therapy Trial.

Authors:  Piret Veerus; Krista Fischer; Sirpa-Liisa Hovi; Helle Karro; Mati Rahu; Elina Hemminki
Journal:  BMC Womens Health       Date:  2008-03-26       Impact factor: 2.809

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.